Testosterone (T) is the major exogenous stimulus for the growth of prostatic carcinoma. It is believed that the proliferative action of T may be mediated by locally expressed growth modulatory factors. Recent evidence from our laboratory suggests that a LHRH (or a LHRH-like) loop might be expressed in human prostatic tumor cells. To verify this hypothesis, we have studied whether a mRNA for LHRH is expressed in the human androgen-responsive prostatic cancer cell line LNCaP, using the reverse transcription-polymerase chain reaction technique in the presence of a pair of specific oligonucleotide primers. A cDNA band of the expected size was obtained from LNCaP cells; this band hybridized with a 32P-labeled LHRH oligonucleotide probe and its s...
markdownabstractAbstract The growth of the majority of prostate tumors is androgen-dependent, for...
Recent evidence suggests a direct antiproliferative effect of LHRH agonists on the prostatic carcino...
markdownabstractAbstract LNCaP cells (derived from a lymph node carcinoma of the human prostate) ...
Recent evidence suggests that LHRH or a LHRH-like peptide might be produced by human prostatic tumor...
Previous work carried out in the authors' laboratory has shown that LHRH agonists directly inhibit t...
The crucial role played by androgens in the growth of prostatic carcinoma is now well established. H...
It is now well accepted that locally produced growth factors play a crucial role in the regulation o...
Evidence has accumulated indicating that LHRH might behave as an autocrine/paracrine growth inhibito...
markdownabstract__Abstract__ The mitogenic activity of several growth factors on androgen respons...
textabstractThis thesis deals with a tumor cell line, named LNCaP, which has been derived from a ly...
The therapeutic options for the treatment of androgen-independent prostatic cancers are rather limit...
textabstractThe effects of androgens, antiandrogens, and other steroid hormones on growth of the hum...
Background Recent studies have shown that GHRH antagonists inhibit prostate tumour growth and IGF-II...
LH-releasing hormone (LHRH) agonists exert a direct inhibitory action on the growth of both androgen...
Our study aimed at understanding the regulation of parathyroid hormone related peptide (PTHRP) by an...
markdownabstractAbstract The growth of the majority of prostate tumors is androgen-dependent, for...
Recent evidence suggests a direct antiproliferative effect of LHRH agonists on the prostatic carcino...
markdownabstractAbstract LNCaP cells (derived from a lymph node carcinoma of the human prostate) ...
Recent evidence suggests that LHRH or a LHRH-like peptide might be produced by human prostatic tumor...
Previous work carried out in the authors' laboratory has shown that LHRH agonists directly inhibit t...
The crucial role played by androgens in the growth of prostatic carcinoma is now well established. H...
It is now well accepted that locally produced growth factors play a crucial role in the regulation o...
Evidence has accumulated indicating that LHRH might behave as an autocrine/paracrine growth inhibito...
markdownabstract__Abstract__ The mitogenic activity of several growth factors on androgen respons...
textabstractThis thesis deals with a tumor cell line, named LNCaP, which has been derived from a ly...
The therapeutic options for the treatment of androgen-independent prostatic cancers are rather limit...
textabstractThe effects of androgens, antiandrogens, and other steroid hormones on growth of the hum...
Background Recent studies have shown that GHRH antagonists inhibit prostate tumour growth and IGF-II...
LH-releasing hormone (LHRH) agonists exert a direct inhibitory action on the growth of both androgen...
Our study aimed at understanding the regulation of parathyroid hormone related peptide (PTHRP) by an...
markdownabstractAbstract The growth of the majority of prostate tumors is androgen-dependent, for...
Recent evidence suggests a direct antiproliferative effect of LHRH agonists on the prostatic carcino...
markdownabstractAbstract LNCaP cells (derived from a lymph node carcinoma of the human prostate) ...